The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Cost and cost-effectiveness analysis of a digital diabetes prevention program: results from the PREDICTS trial
Abstract
Although technology-assisted diabetes prevention programs (DPPs) have been shown to improve glycemic control and weight loss, information are limited regarding relevant costs and their cost-effectiveness. To describe a retrospective within-trial cost and cost-effectiveness analysis (CEA) to compare a digital-based DPP (d-DPP) with small group education (SGE), over a 1-year study period. The costs were summarized into direct medical costs, direct nonmedical costs (i.e., times that participants spent engaging with the interventions), and indirect costs (i.e., lost work productivity costs). The CEA was measured by the incremental cost-effectiveness ratio (ICER). Sensitivity analysis was performed using nonparametric bootstrap analysis. Over 1 year, the direct medical costs, direct nonmedical costs, and indirect costs per participant were $4,556, $1,595, and $6,942 in the d-DPP group versus $4,177, $1,350, and $9,204 in the SGE group. The CEA results showed cost savings from d-DPP relative to SGE based on a societal perspective. Using a private payer perspective for d-DPP, ICERs were $4,739 and $114 to obtain an additional unit reduction in HbA1c (%) and weight (kg), and were $19,955 for an additional unit gain of quality-adjusted life years (QALYs) compared to SGE, respectively. From a societal perspective, bootstrapping results indicated that d-DPP has a 39% and a 69% probability, at a willingness-to-pay of $50,000/QALY and $100,000/QALY, respectively, of being cost-effective. The d-DPP was cost-effective and offers the prospect of high scalability and sustainability due to its program features and delivery modes, which can be easily translated to other settings.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold
Neumann, P. J., Cohen, J. T., & Weinstein, M. C. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1405158 · Cited by 2,249
Organization for Economic Co-operation and Development
Moise, E. (1988) · World Competition Law and Economics Review · doi:10.1016/0048-9697(80)90073-x · Cited by 1,564
Cost-Effectiveness in Health and Medicine
(2016) · doi:10.1093/acprof:oso/9780190492939.001.0001 · Cited by 1,552
(2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00291-0 · Cited by 1,029
The Godin-Shephard Leisure-Time Physical Activity Questionnaire
Godin, G. (2011) · Health & fitness journal of Canada · doi:10.14288/hfjc.v4i1.82 · Cited by 922
Economic Evaluation in Clinical Trials
Glick, H. A., Doshi, J. A., Sonnad, S. S., & Polsky, D. (2014) · Oxford University Press eBooks · doi:10.1093/med/9780199685028.001.0001 · Cited by 910
Claxton, K. (1999) · Journal of Health Economics · doi:10.1016/s0167-6296(98)00039-3 · Cited by 889
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Value in Health · doi:10.1016/j.jval.2021.10.008 · Cited by 847
Organization for Economic Cooperation and Development
(2021) · Permanent Missions to the United Nations · doi:10.18356/9789210056755c215 · Cited by 725
Research works printed but not linked: 2
- International Diabetes Federation, 2021
- Centers for Disease Control and Prevention, 2020, National diabetes statistics report, 2020, 12
Cited by
Abusamaan, M. S., Ballreich, J., Dobs, A., Kane, B., Maruthur, N., McGready, J., Riekert, K., Wanigatunga, A. A., Alderfer, M., Alver, D., et al. (2024) · Trials · doi:10.1186/s13063-024-08177-8 · Cited by 16
Park, S., Ballreich, J. M., Ward, T., & Shi, L. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15807 · Cited by 10
“1,15,16 However, previous studies did not consider adherence to the programme, although it plays a vital role in the effect of in-person and digital DPPs. 17 d-DPP”
Teoh, K. W., Baek, Y., Ademi, Z., & Lee, S. W. H. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16350 · Cited by 9
Aslam, A., Butt, M. D., Javaid, I., Malik, T., Gull, Z., Mahmood, A., Afzal, A., Adnan, A., & Ong, S. C. (2025) · BMC Public Health · doi:10.1186/s12889-025-25319-y · Cited by 8
“Additionally, assessing the cost-effectiveness of different intervention strategies will help ensure that resources are utilized efficiently [53].”
Using Digital Health Technology to Prevent and Treat Diabetes
Clements, M. A., Kaufman, N., & Mel, E. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.2506 · Cited by 1
Metadata
- Authors
- Michaud, T. L., Wilson, K. E., Katula, J. A., You, W., & Estabrooks, P. A.
- Affiliations
- University of Nebraska Medical Center (US)
- Georgia State University (US)
- Wake Forest University (US)
- University of Virginia (US)
- University of Utah (US)
- Corresponding author
- Michaud, Tzeyu L
- Venue
- Translational Behavioral Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-02-21
- Volume
- 13
- Issue
- 7
- Pages
- 501-510
- ISSN
- 1613-9860 (ISSN-L)
- 1869-6716
- OpenAlex
- W4321437515
- Cited by
- 12
- References
- 52
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 7
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Translational Behavioral Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Omada Health
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Keywords
- Diabetes Prevention Program, digital health interventions, cost-effectiveness, small group instruction, HbA1c reduction, weight loss, quality-adjusted life years, incremental cost-effectiveness ratio, type 2 diabetes prevention
- MeSH terms
- Cost-Effectiveness Analysis, Cost-Benefit Analysis, Diabetes Mellitus, Type 2, Humans, Retrospective Studies, Weight Loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost and cost-effectiveness analysis of a digital diabetes prevention program: results from the PREDICTS trial. https://app.cochat.ai/papers/10.1093/tbm/ibad008
- The paper
- Michaud, T. L., Wilson, K. E., Katula, J. A., You, W., & Estabrooks, P. A. (2023). Cost and cost-effectiveness analysis of a digital diabetes prevention program: results from the PREDICTS trial. Translational Behavioral Medicine. https://doi.org/10.1093/tbm/ibad008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.